Simon Baunwall on faecal microbiota transplantation for first or second Clostridioides difficile infection
The Lancet Gastroenterology & Hepatology in conversation with - Ein Podcast von The Lancet Group
Kategorien:
Simon Baunwall (Aarhus University Hospital) discusses the EarlyFMT trial, a randomized placebo-controlled trial of faecal microbiota transplantation for first or second Clostridioides difficile infection. Read the full article: Faecal microbiota transplantation for first or second Clostridioides difficile infection (EarlyFMT) Continue this conversation on social! Follow us today at... https://bsky.app/profile/lancetgastrohep.bsky.social https://www.linkedin.com/company/langastro/ https:/...
